Skip to main content
SpringerLink
Log in
Book cover

The Transplantation and Replacement of Thoracic Organs pp 111–117Cite as

Malignant Neoplasia in the Immunocompromised Patient

  • Chapter

Abstract

The burgeoning numbers of patients who undergo cardiac or pulmonary transplantation make it increasingly important that cardiologists, pulmonologists and cardiothoracic surgeons be familiar with the complications of these treatments. One of these is an increased risk for the development of certain types of cancer. Much of this chapter is based on experience obtained from renal transplantation, but whenever possible observations made in cardiac, cardiopulmonary or pulmonary graft recipients (henceforth referred to as cardiothoracic [CT] recipients) will be stressed. The report is based on data collected by the Cincinnati Transplant Tumor Registry (CTTR) up till May 1995.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Penn I. Donor transmitted disease; cancer. Transplant. Proc. 1991;23:2629.

    PubMed  CAS  Google Scholar 

  2. Penn I. Malignancy in transplanted organs (editorial). Transplant Int. 1993;6:1.

    Article  CAS  Google Scholar 

  3. Penn I. Precautions to be taken to prevent transmission of ncoplastic diseases in the grafting process. In: Englert Y. editor. Organ and tissue transplantation in the European Union: management of difficulties and health risks linked to donors. Dordrecht: Martinus Nijhoff: 1995:47.

    Google Scholar 

  4. Penn I. The effect of renal transplantation in patients with a history of curative cancer therapy. In: Stewart THM, Wheelock HF, editors. Cellular immune mechanisms and tumor dormancy. Boca Raton: CRC Press: 1992:239.

    Google Scholar 

  5. Penn I. Effects of immunosuppression on pre-existing cancers. Transplantation. 1993;55:742.

    Article  PubMed  CAS  Google Scholar 

  6. Penn I. Why do immunosuppressed patients develop cancer? In: Pimemel E, editor. CRC critical reviews in ontogenesis. Boca Raton: CRC Press. 1989;1:27.

    Google Scholar 

  7. Penn I. Tumors after renal and cardiac transplantation. Hematol-Oncol Clin N Am. 1993;7:431.

    CAS  Google Scholar 

  8. Penn I. The problems of cancer in organ Transplant recipients: an overview. Transplant Sci. 1994;4:23

    PubMed  CAS  Google Scholar 

  9. Weintraub J, Warlike RA. Lymphoma in cardiac allograft recipients. Clinical and histological features and immunological phenotype. Transplantation. 1982;33:347.

    Article  PubMed  CAS  Google Scholar 

  10. Lanza RP, Cooper DKC, Cassidy MJC, Barnard CN. Malignancy following cardiac transplantation. J Am Med Assoc. 1993;249:1746.

    Article  Google Scholar 

  11. Bernstein D. Baum D, Berry G et al. Neoplastic disorders after pediatric heart transplantation. Circulation. 1993;88:230.

    Google Scholar 

  12. Sheil AGR, Disney APS, Mathew TH, Amiss N. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc. 1993;25:1383.

    PubMed  CAS  Google Scholar 

  13. Sheil AGR. Skin cancer in renal transplant recipients. Transplant Sci. 1994;4:42.

    PubMed  CAS  Google Scholar 

  14. Btohme I. Brynger H. Malignant disease in renal transplant patients. Transplantation. 1985;39:23.

    Google Scholar 

  15. Kinlen LJ, Sheil AGR. Peto J, Doll R. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J. 1979;2:1461.

    Article  PubMed  CAS  Google Scholar 

  16. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment, Am J Med 1985;78:44.

    Article  PubMed  CAS  Google Scholar 

  17. Harwood AR, Osaba D, Hofstader SL et al. Kaposi’s sarcoma in recipients of renal transplants. Am J Med. 1979;67:759.

    Article  PubMed  CAS  Google Scholar 

  18. Porrecco R, Penn I, Droegemueller W, Greer B, Makowski E. Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol. 1975;45:359.

    Google Scholar 

  19. Hartevelt MM, Bouwes-Bavinck JN, Koote AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation. 1990;49:506.

    Article  PubMed  CAS  Google Scholar 

  20. Mullen DL, Silberberg SG, Penn I. Hammond WS. Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer. 1976;37:729.

    Article  PubMed  CAS  Google Scholar 

  21. Penn I, Porat G. Central nervous system lymphomas in organ allograft recipients. Transplantation. 1995;59:240.

    PubMed  CAS  Google Scholar 

  22. Nalcsnik MA. Starzl. TH. Epstein-Barr virus, infectious mononucleosis, and post-transplant lymphoproliferative disorders. Transplant Sci. 1994;4:61.

    Google Scholar 

  23. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lyinpho-proliferative diseases: implications for understanding their palhogenesis and developing rational treatment strategies. Annu Rev Med. 1995;46:381.

    Article  PubMed  CAS  Google Scholar 

  24. Penn I. Kaposi’s sarcoma-etiology: immunodeficiency In: Ziegler JL, Dorfman RF, editors. Kaposi’s sarcoma, pathophysiology and clinical management. New York: Marcel Dekker: 1988:129.

    Google Scholar 

  25. Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases. Cancer. 1986;58:61.

    Article  Google Scholar 

  26. Sillman F, Stanek A, Sedlis A et al. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol. 1984;150:300.

    PubMed  CAS  Google Scholar 

  27. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation. 1995;59:480.

    PubMed  CAS  Google Scholar 

  28. Ishikawa I. Acquired cysts and neoplasms of the kidney in renal allograft recipients. In: Berlyne GM. editor. The kidney today: selected topics in renal science. Basel, Karger: Contrib. Nephrol. 1992;100:254.

    Google Scholar 

  29. Shroter GPJ, Weil R III. Penn I, Speers WC. Wuddell WR. Hepatocellular carcinoma associated with chronic hepatitis B virus infection alter kidney transplantation (Letter). Lancet. 1982;2:381.

    Article  Google Scholar 

  30. Barret WL, First R, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer. 1993;72:2186

    Article  Google Scholar 

  31. Nalesnik MA, Locker J, Jaffe R et al. Experience with posttransplant lymphoprolife erative disorders in solid organ transplant recipients. Clin Transpl. 1492;6:249.

    Google Scholar 

  32. Brumbaugh J, Baldwin JC, Stinson EB et al. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma. J Heart Transplant. 1985;4:307.

    PubMed  CAS  Google Scholar 

  33. Eurvard S, Verschoore M. Touraine JL et al. Topical retinoids for warts and keratoses in transplant recipients (Letter). Lancet. 1992;340:48.

    Google Scholar 

  34. Magnone M, Holley JL, Shapiro R et al. Inlerferon-alpha-indueed acute renal allograft rejection. Transplantation. 1995;59:1068.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. I. Penn
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston

    David K. C. Cooper MA, PhD, MD, MS, FRCS, FACC, FACS

  2. Oklahoma Medical Research Foundation, Oklahoma City, USA

    David K. C. Cooper MA, PhD, MD, MS, FRCS, FACC, FACS

  3. St Louis University Health Sciences Center, St Louis, USA

    Leslie W. Miller MD, FACC

  4. Washington University School of Medicine, St Louis, USA

    G. Alexander Patterson MD, FRCS(C), FACS

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Kluwer Academic Publishers

About this chapter

Cite this chapter

Penn, I. (1996). Malignant Neoplasia in the Immunocompromised Patient. In: Cooper, D.K.C., Miller, L.W., Patterson, G.A. (eds) The Transplantation and Replacement of Thoracic Organs. Springer, Dordrecht. https://doi.org/10.1007/978-0-585-34287-0_12

Download citation

  • DOI: https://doi.org/10.1007/978-0-585-34287-0_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-8898-2

  • Online ISBN: 978-0-585-34287-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation